Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status:
Terminated
Trial end date:
2021-07-14
Target enrollment:
Participant gender:
Summary
This study is being conducted to demonstrate that perampanel given as adjunctive
anti-epileptic treatment is superior to placebo in reducing the number of drop seizures in
participants with inadequately controlled seizures associated with Lennox-Gastaut Syndrome
(LGS).